Skip to main content
Freddy Caldera Jr., DO, Gastroenterology, Madison, WI

FreddyCalderaJr.DOMS

Gastroenterology Madison, WI

Inflammatory Bowel Disease

Assistant Professor, Medicine, University of Wisconsin Medical School

Dr. Caldera is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Caldera's full profile

Already have an account?

  • Office

    1685 Highland Ave
    # 4256
    Madison, WI 53705
    Phone+1 608-263-1995

Summary

  • Dr. Caldera specializes in the care and treatment of patients with inflammatory bowel disease, Crohn's Disease and ulcerative colitis.
  • Freddy Caldera, DO, UW Health Gastroenterology and Hepatology

Education & Training

  • University of Kentucky College of Medicine
    University of Kentucky College of MedicineFellowship, Gastroenterology, 2008 - 2011
  • University of Kentucky College of Medicine
    University of Kentucky College of MedicineResidency, Internal Medicine, 2005 - 2008
  • Des Moines University College of Osteopathic Medicine
    Des Moines University College of Osteopathic MedicineClass of 2004

Certifications & Licensure

  • WI State Medical License
    WI State License 2011 - 2025
  • KY State Medical License
    KY State License 2008 - 2012
  • American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Immunosuppression Does Not Affect Antibody Concentrations to Measles, Mumps, and Rubella in Patients with Inflammatory Bowel Disease  
    Mark Reichelderfer, Arnold Wald, Jeffrey Hubers, Freddy Caldera, Sumona Saha, Elizabeth Ann Misch, Mary S Hayney, Digestive Diseases and Sciences

Press Mentions

  • Breakthrough COVID-19 Milder in Vaccinated Patients with IBD
    Breakthrough COVID-19 Milder in Vaccinated Patients with IBDFebruary 14th, 2022
  • COVID-19 Vaccine Booster Benefits ‘Outweigh Risks’ Among Immunocompromised
    COVID-19 Vaccine Booster Benefits ‘Outweigh Risks’ Among ImmunocompromisedNovember 22nd, 2021
  • UW Study Finds Most Patients with Inflammatory Bowel Disease Have Immune Response to COVID-19 Vaccine; Expands Enrollment
    UW Study Finds Most Patients with Inflammatory Bowel Disease Have Immune Response to COVID-19 Vaccine; Expands EnrollmentSeptember 8th, 2021
  • Join now to see all

Professional Memberships